Preclinical PET Neuroimaging of [(11)C]Bexarotene

Activation of retinoid X receptors (RXRs) has been proposed as a therapeutic mechanism for the treatment of neurodegeneration, including Alzheimer's and Parkinson's diseases. We previously reported radiolabeling of a Food and Drug Administration-approved RXR agonist, bexarotene, by copper-...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Mol Imaging
Autors principals: Rotstein, Benjamin H., Placzek, Michael S., Krishnan, Hema S., Pekošak, Aleksandra, Collier, Thomas Lee, Wang, Changning, Liang, Steven H., Burstein, Ethan S., Hooker, Jacob M., Vasdev, Neil
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2016
Matèries:
Brief Report
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5011434/
https://ncbi.nlm.nih.gov/pubmed/27553293
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1536012116663054
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars